Stock MREO MEREO BIOPHARMA GROUP PLC
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Mereo BioPharma Group plc

Equities

MREO

US5894921072

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
2.78 USD -0.36% Intraday chart for Mereo BioPharma Group plc +3.35% +20.35%
Apr. 09 European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading MT
Apr. 08 European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading MT

Evolution of the average Target Price on Mereo BioPharma Group plc

Price target over the last 5 years

History of analyst recommendation changes

4779d4e529457bcb8a5338c7e.eKmujGwOJ_kGoQ1Yy0NBpyCr7Z2S727sAkxei0zUL2A.QNnZzhtZaY1Z-28gghYzkmSdj-nW3BeGaxVr5CuxTS099s_qO2lhu3TXfg~c06f61e368b790e97bf26c9840c705c9

Analyst Recommendations on Mereo BioPharma Group plc

Needham Adjusts Price Target on Mereo BioPharma to $6 From $5, Keeps Buy Rating MT
Ultragenyx and Mereo BioPharma Announce Interim Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Setrusumab Significantly Reduced Fracture Rates in Patients with Osteogenesis Imperfecta (OI) CI
Shift to Fed's Rate Hike Path, Better Outlook on UBS-Credit Suisse Deal Pushes US Equities Up MT
European Equities Move Lower Following ECB Rate Hike MT
SVB Securities Trims Price Target on Mereo BioPharma Group to $4 From $8, Maintains Outperform Rating MT
Cantor Fitzgerald Starts Mereo BioPharma Group at Overweight With $4 Price Target MT
Needham Adjusts Price Target on Mereo BioPharma Group to $5 From $10, Reiterates Buy Rating MT
MEREO BIOPHARMA : BTIG Initiates Mereo BioPharma at Buy Rating With $10 Price Target MT
MEREO BIOPHARMA : Needham Starts Mereo BioPharma Group at Buy With $10 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.235 GBP
Average target price
4.573 GBP
Spread / Average Target
+104.62%
High Price Target
5.629 GBP
Spread / Highest target
+151.89%
Low Price Target
3.164 GBP
Spread / Lowest Target
+41.58%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Mereo BioPharma Group plc

Needham & Co.
SVB Securities LLC
Cantor Fitzgerald
BTIG

Ratings for Mereo BioPharma Group plc

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MREO Stock
  4. Consensus Mereo BioPharma Group plc